Nrx Pharmaceuticals Stock Analysis

NRX Stock Analysis Notes

About 24.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 2.11. NRX Pharmaceuticals had not issued any dividends in recent years. The entity had 1:10 split on the 2nd of April 2024. NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded in 2015 and is based in Wilmington, Delaware. Nrx Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. To find out more about NRX Pharmaceuticals contact Stephen Esq at (484) 254-6134 or learn more at https://www.nrxpharma.com.

NRX Pharmaceuticals Investment Alerts

NRX Pharmaceuticals Upcoming and Recent Events

NRX Largest EPS Surprises

View All Earnings Estimates

NRX Stock Institutional Investors

Note, although NRX Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

NRX Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 15.6 M.

NRX Profitablity

Management Efficiency

NRX Pharmaceuticals has return on total asset (ROA) of (1.1597) % which means that it has lost $1.1597 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (6.8261) %, meaning that it created substantial loss on money invested by shareholders. NRX Pharmaceuticals' management efficiency ratios could be used to measure how well NRX Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. At this time, NRX Pharmaceuticals' Return On Capital Employed is relatively stable compared to the past year. As of 11/29/2024, Return On Equity is likely to grow to 2.70, though Return On Tangible Assets are likely to grow to (3.92). Change To Liabilities is expected to grow at the current pace this year, while Total Current Liabilities is likely to drop slightly above 14.9 M.

Technical Drivers

As of the 29th of November, NRX Pharmaceuticals secures the Mean Deviation of 2.9, market risk adjusted performance of (0.31), and Risk Adjusted Performance of (0.1). Concerning fundamental indicators, the technical analysis model lets you check available technical drivers of NRX Pharmaceuticals, as well as the relationship between them.

NRX Pharmaceuticals Price Movement Analysis

NRX Pharmaceuticals Insider Trading Activities

NRX Pharmaceuticals Outstanding Bonds

NRX Pharmaceuticals Predictive Daily Indicators

NRX Pharmaceuticals Forecast Models

NRX Pharmaceuticals' time-series forecasting models are one of many NRX Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary NRX Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how NRX Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling NRX shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as NRX Pharmaceuticals. By using and applying NRX Stock analysis, traders can create a robust methodology for identifying NRX entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. NRX analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. NRX analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

NRX Pharmaceuticals stock analysis indicators help investors evaluate how NRX Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading NRX Pharmaceuticals shares will generate the highest return on investment. By understating and applying NRX Pharmaceuticals stock analysis, traders can identify NRX Pharmaceuticals position entry and exit signals to maximize returns.

When running NRX Pharmaceuticals' price analysis, check to measure NRX Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRX Pharmaceuticals is operating at the current time. Most of NRX Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRX Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRX Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRX Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.